Journal of Oncology / 2022 / Article / Tab 3 / Research Article
Chemotherapy of Capecitabine plus Temozolomide for Refractory Pituitary Adenoma after Tumor Resection and Its Impact on Serum Prolactin, IGF-1, and Growth Hormone Table 3 Serum levels of PRL, IGH-1, and GH (
, ng/mL).
PRL IGF-1 GH Before After Before After Before After Control group (n = 40) 372.44 ± 34.21 326.35 ± 42.45 468.38 ± 46.26 364.35 ± 31.35 13.54 ± 3.13 8.34 ± 2.14 Study group (n = 40) 384.15 ± 40.32 278.35 ± 39.25 455.25 ± 52.17 311.78 ± 28.82 14.03 ± 4.21 5.44 ± 1.46 t 1.400 5.251 1.191 7.808 0.581 7.078 0.165 <0.001 0.237 <0.001 0.563 <0.001
PRL, prolactin; IGF-1, insulin-like growth factor 1; GH, growth hormone.